Latest Whitepapers

In this interview, delve into the significance of measuring immune mediators with high sensitivity, revolutionizing our understanding of disease dynamics.

This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.

These advances owe much to increased raw sequencing power and ever-more ingenious techniques for sampling genomic data, but these advances would be for naught if we weren’t able to process and analyze the data torrent that pours from these sequencing projects.

This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.

This whitepaper highlights the latest bioprocessing film technologies to help you meet your upstream and downstream needs.

This whitepaper explores how to track HCPs of concern through purification steps, develop robust removal strategies and increase the HCP population coverage achieved.

Genomics, proteomics and microbiomics are all useful tools in complex disease research. However, using these tools alone can risk critical knowledge gaps and leave researchers struggling to predict disease outcomes.

These whitepapers highlight how optimized CRISPR protocols and site-specific knock-in technology can be used to engineer simple or complex genetic modifications in allogenic iPSCs.

Flow cytometry is a core technique in many immunology labs.. However, extensive immunophenotyping panels can result in overlapping emission peaks, time-consuming compensation and complex data analysis.